{"data":{"id":"us-in/ic-16-40-6-1","jurisdiction":"us-in","citation":"IC 16-40-6-1","heading":"\"340B covered entity\"","body":"Sec. 1. (a) As used in this chapter, \"340B covered entity\" means an entity described in 42 U.S.C. 256b(a)(4)(L) through 42 U.S.C. 256b(a)(4)(O) that:\n(1) is authorized to participate in the federal 340B Drug Pricing Program under Section 340B of the federal Public Health Service Act (42 U.S.C. 256b(a)(4)); and\n(2) has a service address in Indiana as of January 1 of the reporting year.\n(b) The term includes any offsite outpatient facility affiliated under the 340B program with an entity described in subsection (a).","path":["TITLE 16. HEALTH","ARTICLE 40. OTHER REPORTING REQUIREMENTS","Chapter 6. 340B Drug Pricing Program Reporting"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-40-6-1","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"2e86d359450031bb9c108508a6475ef59d3b6d23c767a39a546efb88aa1247ac","source_id":"us-in","stale":false,"prev":"us-in/ic-16-40-4-10","next":"us-in/ic-16-40-6-2"},"notice":"GroundRules: Original legal text. Not legal advice."}